James Hambro & Partners
ABBV icon

James Hambro & Partners’s AbbVie ABBV Stock Holding History

James Hambro & Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$520K Sell
1,988
-103
-5% -$26.4K 0.02% 49
2026
Q2 		$526K Buy
2,091
+1
+0% +$215 0.02% 49
2026
Q1 		$454K Buy
2,090
+435
+26% +$96.5K 0.02% 43
2025
Q4 		$378K Hold
1,655
– – 0.01% 43
2025
Q3 		$383K Sell
1,655
-95
-5% -$19.3K 0.01% 47
2025
Q2 		$325K Hold
1,750
– – 0.01% 44
2025
Q1 		$367K Hold
1,750
– – 0.02% 47
2024
Q4 		$311K Sell
1,750
-235
-12% -$43.2K 0.01% 51
2024
Q3 		$392K Hold
1,985
– – 0.02% 47
2024
Q2 		$340K Sell
1,985
-79
-4% -$13.1K 0.02% 46
2024
Q1 		$375K Buy
2,064
+79
+4% +$13.6K 0.02% 45
2023
Q4 		$308K Sell
1,985
-170
-8% -$24.8K 0.02% 46
2023
Q3 		$321K Hold
2,155
– – 0.02% 46
2023
Q2 		$290K Buy
2,155
+391
+22% +$57.3K 0.02% 54
2023
Q1 		$281K Buy
1,764
+4
+0.2% +$612 0.02% 59
2022
Q4 		$284K Sell
1,760
-40
-2% -$6.13K 0.02% 58
2022
Q3 		$241K Sell
1,800
-30
-2% -$4.3K 0.02% 58
2022
Q2 		$281K Sell
1,830
-110
-6% -$16.8K 0.02% 53
2022
Q1 		$315K Buy
1,940
+350
+22% +$50.8K 0.02% 55
2021
Q4 		$216K Buy
+1,590
New +$188K 0.01% 71

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

James Hambro & Partners's ABBV Position: Q3 2026 in Review

James Hambro & Partners reduced its AbbVie (ABBV) stake by 4.9% in Q3 2026, selling an estimated $26.4K and leaving 1,988 shares worth $520K. The position accounts for 0.02% of the portfolio, ranked #49.

James Hambro & Partners first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. The position peaked at $526K in Q2 2026. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • James Hambro & Partners held 1,988 shares of AbbVie worth $520K as of Q3 2026.
  • James Hambro & Partners sold 103 AbbVie shares in Q3 2026, an estimated $26.4K.
  • AbbVie made up 0.02% of James Hambro & Partners's portfolio in Q3 2026, its #49 holding.
  • James Hambro & Partners first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
  • James Hambro & Partners's AbbVie position peaked at $526K in Q2 2026.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on James Hambro & Partners's 13F filing for Q3 2026, filed 19 Oct 2026.